Virtual sarcoma disease multidisciplinary team
A successful experience in the era of telemedicine and Covid-19 in Italy
Bibliographic Data
| ID | 22066689 |
|---|---|
| Authors | Francesca Salvatori (0000-0001-8950-9978, Sapienza University of Rome), Barbara Rossi (0000-0002-4358-5243, National Cancer Institute), Concetta Elisa Onesti (0000-0002-8360-5026, National Cancer Institute, corresponding author), Sabrina Vari (0000-0002-6854-4771, National Cancer Institute), Serena Ceddia (0000-0001-7692-1998, National Cancer Institute), Elisa Checcucci (National Cancer Institute), Antonella Cosimati (0000-0002-2636-3198, National Cancer Institute), Federica Riva (0000-0002-1270-1627, National Cancer Institute), Davide Renna (0000-0002-1688-3210, Radiation Oncology Institute), R Biagini (0000-0002-6819-2841, National Cancer Institute), Virginia Ferraresi (0000-0001-6419-1668, National Cancer Institute) |
| Year | 2025 |
| Volume | 13 |
| Pages | 1636095-1636095 |
| Publication date | 2025-11-06 |
| Open Access | Yes |
| Type | ARTICLE |
| Venue | Frontiers in Public Health (JOURNAL) |
| Journal identifiers | ISSN: 2296-2565 • E-ISSN: 2296-2565 |
| Publisher | Frontiers Media SA (PUBLISHER • CH) |
| DOI | 10.3389/fpubh.2025.1636095 |
| PMID | 41283041 |
| OpenAlex | W4415961054 |
| Language | EN |
| References cited | 19 |
Background Due to their rarity and complexity sarcomas require specialized multidisciplinary team management. COVID-19 pandemic brought to a rapid implementation of telemedicine and activation of digital tools. This study evaluates the perception of virtual disease multidisciplinary team among healthcare professionals of an European rare cancer referral center. Methods An online survey was administered to the participants of Regina Elena National Cancer Institute’s Sarcoma disease multidisciplinary team meetings held between 2020 and 2022. It was composed of 40 questions comparing face-to-face and virtual meetings. Data from the Institutional disease multidisciplinary team from 2019 to 2022 were also analyzed retrospectively to compare the pre-covid, covid, and post-covid phases. Results Twenty-two healthcare professionals answered the survey. In their opinion, decision-making process was not affected by virtual modality (86.0%). Regarding virtual meetings 90.0% were highly/moderately satisfied with depth of discussion, 95.0%–100% were able to interact adequately and access all relevant data. The most important improvements of virtual disease multidisciplinary team were better quality of clinical approach/research (22.7%–31.8%), technological innovations (50.0%), and logistical setting (95.5%). 90.0% to 100% thought that virtual disease multidisciplinary team could be approved thereafter. We observed an increase in participation rate from 58.0, to 62.0%, to 64.0% ( p = 0.0159) and a rise in the new cases discussed at meetings compared to the re-discussed ones from 30.1% to 37.9% to 42.3% ( p < 0.0001) in the pre-covid, covid, and post-covid phases, respectively. Conclusion Virtual disease multidisciplinary team enhances participation and discussion quality without compromising patient care
Disease · MEDLINE · Multidisciplinary approach · Multidisciplinary team · Telemedicine · COVID-19 and healthcare impacts · Interdisciplinary Research and Collaboration · Interprofessional Education and Collaboration
| Highly cited | No |
|---|